479 related articles for article (PubMed ID: 25631522)
21. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
[TBL] [Abstract][Full Text] [Related]
22. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of preoperative renal function and gross hematuria for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.
Hashimoto T; Nakashima J; Kashima T; Hirasawa Y; Shimodaira K; Gondo T; Nakagami Y; Namiki K; Horiguchi Y; Ohno Y; Ohori M; Tachibana M
Int J Urol; 2017 Feb; 24(2):111-116. PubMed ID: 27875859
[TBL] [Abstract][Full Text] [Related]
24. Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma.
Krabbe LM; Bagrodia A; Lotan Y; Gayed BA; Darwish OM; Youssef RF; John G; Harrow B; Jacobs C; Gaitonde M; Sagalowsky AI; Shariat SF; Kapur P; Margulis V
J Urol; 2014 Jan; 191(1):28-34. PubMed ID: 23871758
[TBL] [Abstract][Full Text] [Related]
25. Does Xylinas' nomogram accurately predict intravesical recurrence risk after radical nephroureterectomy for primary upper urinary tract urothelial carcinoma when applied to Asian populations?
Lai S; Wu P; Diao T; Seery S; Liu J; Hou H; Liu M; Wang J
Jpn J Clin Oncol; 2021 Mar; 51(3):469-477. PubMed ID: 32734304
[TBL] [Abstract][Full Text] [Related]
26. Effect of Adjuvant Systemic Chemotherapy on Intravesical Recurrence After Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma.
Yamaguchi N; Morizane S; Yumioka T; Shimizu R; Teraoka S; Iwamoto H; Hikita K; Honda M; Takenaka A
Anticancer Res; 2023 Apr; 43(4):1725-1730. PubMed ID: 36974830
[TBL] [Abstract][Full Text] [Related]
27. Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract.
Ohtsuka Y; Kawakami S; Fujii Y; Koga F; Saito K; Ando N; Takizawa T; Kageyama Y; Kihara K
BJU Int; 2006 Jun; 97(6):1322-6. PubMed ID: 16686732
[TBL] [Abstract][Full Text] [Related]
28. Intravesical seeding of upper urinary tract urothelial carcinoma cells during nephroureterectomy: an exploratory analysis from the THPMG trial.
Ito A; Shintaku I; Satoh M; Ioritani N; Tochigi T; Numata I; Namima T; Kambe K; Kyan A; Ueno S; Katoh S; Adachi H; Yamashita S; Yamaguchi T; Arai Y;
Jpn J Clin Oncol; 2013 Nov; 43(11):1139-44. PubMed ID: 24006504
[TBL] [Abstract][Full Text] [Related]
29. Predictors of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: an inflammation-based prognostic score.
Cho YH; Seo YH; Chung SJ; Hwang I; Yu HS; Kim SO; Jung SI; Kang TW; Kwon DD; Park K; Hwang JE; Heo SH; Kim GS; Hwang EC
Korean J Urol; 2014 Jul; 55(7):453-9. PubMed ID: 25045443
[TBL] [Abstract][Full Text] [Related]
30. Independent prognostic factors for initial intravesical recurrence after laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma.
Liu Y; Lu J; Hong K; Huang Y; Ma L
Urol Oncol; 2014 Feb; 32(2):146-52. PubMed ID: 23628312
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors for upper urinary tract urothelial carcinoma after nephroureterectomy.
Kuroda K; Asakuma J; Horiguchi A; Tasaki S; Yoshii H; Sato A; Ito K; Seguchi K; Sumitomo M; Asano T
Urol Int; 2012; 88(2):225-31. PubMed ID: 22236640
[TBL] [Abstract][Full Text] [Related]
32. Over-expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma.
Li WM; Huang CN; Lee YC; Chen SH; Lin HH; Wu WJ; Li CC; Yeh HC; Chang LL; Hsu WC; Ke HL
Int J Med Sci; 2017; 14(13):1360-1367. PubMed ID: 29200949
[No Abstract] [Full Text] [Related]
33. Does adequate bladder cuff excision impact outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma.
Hou CP; Chang PL; Chen CL; Lin YH; Tsui KH
Chang Gung Med J; 2011; 34(5):496-505. PubMed ID: 22035894
[TBL] [Abstract][Full Text] [Related]
34. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
[TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of fatty acid synthase expression in upper urinary tract urothelial carcinoma.
Hamada S; Horiguchi A; Asano T; Kuroda K; Asakuma J; Ito K; Asano T; Miyai K; Iwaya K
Jpn J Clin Oncol; 2014 May; 44(5):486-92. PubMed ID: 24643292
[TBL] [Abstract][Full Text] [Related]
36. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; MartÃnez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
[TBL] [Abstract][Full Text] [Related]
37. Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection.
Espiritu PN; Sverrisson EF; Sexton WJ; Pow-Sang JM; Poch MA; Dhillon J; Spiess PE
Urol Oncol; 2014 Jul; 32(5):619-24. PubMed ID: 24495448
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery.
Koda S; Mita K; Shigeta M; Usui T
Jpn J Clin Oncol; 2007 Apr; 37(4):296-301. PubMed ID: 17513309
[TBL] [Abstract][Full Text] [Related]
39. BUBR1 overexpression predicts disease-specific survival after nephroureterectomy in patients with upper tract urothelial carcinoma.
Yamamoto Y; Oga A; Akao J; Misumi T; Fuji N; Kobayashi K; Kawai Y; Inoue R; Hirata H; Matsumoto H; Nagao K; Sakano S; Matsuyama H
Jpn J Clin Oncol; 2016 Aug; 46(8):754-61. PubMed ID: 27174960
[TBL] [Abstract][Full Text] [Related]
40. Oncologic Outcomes of Patients Undergoing Diagnostic Ureteroscopy Before Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinomas: A Systematic Review and Meta-Analysis.
Liu Z; Zheng S; Li X; Guo S; Wang Y; Zhou F; Liu ZW
J Laparoendosc Adv Surg Tech A; 2018 Nov; 28(11):1316-1325. PubMed ID: 29873581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
